New Zealand markets closed

PT Kalbe Farma Tbk. (KLBF.JK)

Jakarta - Jakarta Delayed price. Currency in IDR
Add to watchlist
1,570.00+5.00 (+0.32%)
At close: 04:03PM WIB

PT Kalbe Farma Tbk.

Gedung KALBE
Jl. Let. Jend. Suprapto Kav. 4 Cempaka Putih
Jakarta 10510
62 21 4287 3888

IndustryDrug Manufacturers - General
Full-time employees13,062

Key executives

NameTitlePayExercisedYear born
Mr. . VidjongtiusPresident DirectorN/AN/A1964
Ms. Lanny SoputroDirector of Human Resources, General Affairs & HSSEN/AN/A1964
Mr. Sie DjohanDirector of Corporate Business Development, Management System & Regulatory Affairs and DirectorN/AN/A1967
Mr. Rustam TanHead of Internal Audit UnitN/AN/A1970
Maria Teresa FabiolaCorporate SecretaryN/AN/A1972
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.


PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Corporate governance

PT Kalbe Farma Tbk.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.